.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Argus Health
Fuji
Dow
Harvard Business School
Moodys
Teva
Deloitte
UBS
QuintilesIMS

Generated: December 18, 2017

DrugPatentWatch Database Preview

Mechanism of Action: Prostaglandin Receptor Agonists

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oak Pharms IncZIOPTANtafluprostSOLUTION/DROPS;OPHTHALMIC202514-001Feb 10, 2012RXYesYes► Subscribe► SubscribeYY► Subscribe
Oak Pharms IncZIOPTANtafluprostSOLUTION/DROPS;OPHTHALMIC202514-001Feb 10, 2012RXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And UpjohnPROSTIN VR PEDIATRICalprostadilINJECTABLE;INJECTION018484-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Mylan Speciality LpMUSEalprostadilSUPPOSITORY;URETHRAL020700-002Nov 19, 1996RXYesYes► Subscribe► Subscribe► Subscribe
Mylan Speciality LpMUSEalprostadilSUPPOSITORY;URETHRAL020700-003Nov 19, 1996RXYesYes► Subscribe► Subscribe► Subscribe
Mylan Speciality LpMUSEalprostadilSUPPOSITORY;URETHRAL020700-004Nov 19, 1996RXYesYes► Subscribe► Subscribe► Subscribe
Mylan Speciality LpMUSEalprostadilSUPPOSITORY;URETHRAL020700-001Nov 19, 1996RXYesYes► Subscribe► Subscribe► Subscribe
Auxilium Pharms LlcEDEXalprostadilINJECTABLE;INJECTION020649-005Jul 30, 1998RXYesYes► Subscribe► Subscribe► Subscribe
Auxilium Pharms LlcEDEXalprostadilINJECTABLE;INJECTION020649-003Jun 12, 1997APRXYesNo► Subscribe► Subscribe► Subscribe
Auxilium Pharms LlcEDEXalprostadilINJECTABLE;INJECTION020649-006Jul 30, 1998RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Moodys
Harvard Business School
AstraZeneca
Healthtrust
Merck
Novartis
Boehringer Ingelheim
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot